New Results
SOX2 expression identifies Ewing sarcoma patients with high risk for tumor relapse and poor survival
View ORCID ProfileGiuseppina Sannino, View ORCID ProfileAruna Marchetto, View ORCID ProfileAndreas Ranft, Susanne Jabar, Constanze Zacherl, Rebeca Alba-Rubio, Stefanie Stein, Fabienne S. Wehweck, Merve M Kiran, View ORCID ProfileTilman L. B. Hoelting, View ORCID ProfileJulian Musa, View ORCID ProfileLaura Romero-Perez, View ORCID ProfileFlorencia Cidre-Aranaz, View ORCID ProfileMaximilian M. L. Knott, View ORCID ProfileJing Li, Heribert Juergens, Ana Sastre, Javier Alonso, Wilian Da Silveira, Gary Hardiman, View ORCID ProfileJulia S. Gerke, View ORCID ProfileMartin F. Orth, View ORCID ProfileWolfgang Hartmann, Thomas Kirchner, View ORCID ProfileShunya Ohmura, Uta Dirksen, View ORCID ProfileThomas G. P. Grunewald
doi: https://doi.org/10.1101/498253
Giuseppina Sannino
1 Max-Eder Research Group for Pediatric Sarcoma Biology, Institute of Pathology, LMU Munich, Germany;
Aruna Marchetto
1 Max-Eder Research Group for Pediatric Sarcoma Biology, Institute of Pathology, LMU Munich, Germany;
Andreas Ranft
2 Department of Pediatrics III, West German Cancer Centre, University Hospital of Essen, Germany;
Susanne Jabar
2 Department of Pediatrics III, West German Cancer Centre, University Hospital of Essen, Germany;
Constanze Zacherl
1 Max-Eder Research Group for Pediatric Sarcoma Biology, Institute of Pathology, LMU Munich, Germany;
Rebeca Alba-Rubio
1 Max-Eder Research Group for Pediatric Sarcoma Biology, Institute of Pathology, LMU Munich, Germany;
Stefanie Stein
1 Max-Eder Research Group for Pediatric Sarcoma Biology, Institute of Pathology, LMU Munich, Germany;
Fabienne S. Wehweck
1 Max-Eder Research Group for Pediatric Sarcoma Biology, Institute of Pathology, LMU Munich, Germany;
Merve M Kiran
3 Department of Pathology, Medical Faculty, Ankara Yildirim Beyazit University, Ankara, Turkey;
Tilman L. B. Hoelting
1 Max-Eder Research Group for Pediatric Sarcoma Biology, Institute of Pathology, LMU Munich, Germany;
Julian Musa
1 Max-Eder Research Group for Pediatric Sarcoma Biology, Institute of Pathology, LMU Munich, Germany;
Laura Romero-Perez
1 Max-Eder Research Group for Pediatric Sarcoma Biology, Institute of Pathology, LMU Munich, Germany;
Florencia Cidre-Aranaz
1 Max-Eder Research Group for Pediatric Sarcoma Biology, Institute of Pathology, LMU Munich, Germany;
Maximilian M. L. Knott
1 Max-Eder Research Group for Pediatric Sarcoma Biology, Institute of Pathology, LMU Munich, Germany;
Jing Li
1 Max-Eder Research Group for Pediatric Sarcoma Biology, Institute of Pathology, LMU Munich, Germany;
Heribert Juergens
4 Department of Pediatric Hematology and Oncology, University Hospital Muenster, Muenster, Germany;
Ana Sastre
5 Unidad hemato-oncologia pediatrica, Hospital Infantil Universitario La Paz, Madrid, Spain;
Javier Alonso
6 Pediatric Solid Tumor Laboratory, Institute of Rare Diseases Research (IIER), Madrid, Spain;
Wilian Da Silveira
7 Center for Genomics Medicine, Medical University of South Carolina, Charleston, SC, USA;
Gary Hardiman
8 School of Biological Sciences and Institute for Global Food Security, Queens University Belfast, UK;
Julia S. Gerke
1 Max-Eder Research Group for Pediatric Sarcoma Biology, Institute of Pathology, LMU Munich, Germany;
Martin F. Orth
1 Max-Eder Research Group for Pediatric Sarcoma Biology, Institute of Pathology, LMU Munich, Germany;
Wolfgang Hartmann
9 Gerhard-Domagk Institute of Pathology, University Hospital of Muenster, Muenster, Germany;
Thomas Kirchner
10 Institute of Pathology, LMU Munich, Germany;
Shunya Ohmura
1 Max-Eder Research Group for Pediatric Sarcoma Biology, Institute of Pathology, LMU Munich, Germany;
Uta Dirksen
11 Department of Pediatrics III, West German Cancer Centre, University Hospital of Essen, Essen, German
Thomas G. P. Grunewald
1 Max-Eder Research Group for Pediatric Sarcoma Biology, Institute of Pathology, LMU Munich, Germany;
Article usage
Posted December 17, 2018.
SOX2 expression identifies Ewing sarcoma patients with high risk for tumor relapse and poor survival
Giuseppina Sannino, Aruna Marchetto, Andreas Ranft, Susanne Jabar, Constanze Zacherl, Rebeca Alba-Rubio, Stefanie Stein, Fabienne S. Wehweck, Merve M Kiran, Tilman L. B. Hoelting, Julian Musa, Laura Romero-Perez, Florencia Cidre-Aranaz, Maximilian M. L. Knott, Jing Li, Heribert Juergens, Ana Sastre, Javier Alonso, Wilian Da Silveira, Gary Hardiman, Julia S. Gerke, Martin F. Orth, Wolfgang Hartmann, Thomas Kirchner, Shunya Ohmura, Uta Dirksen, Thomas G. P. Grunewald
bioRxiv 498253; doi: https://doi.org/10.1101/498253
SOX2 expression identifies Ewing sarcoma patients with high risk for tumor relapse and poor survival
Giuseppina Sannino, Aruna Marchetto, Andreas Ranft, Susanne Jabar, Constanze Zacherl, Rebeca Alba-Rubio, Stefanie Stein, Fabienne S. Wehweck, Merve M Kiran, Tilman L. B. Hoelting, Julian Musa, Laura Romero-Perez, Florencia Cidre-Aranaz, Maximilian M. L. Knott, Jing Li, Heribert Juergens, Ana Sastre, Javier Alonso, Wilian Da Silveira, Gary Hardiman, Julia S. Gerke, Martin F. Orth, Wolfgang Hartmann, Thomas Kirchner, Shunya Ohmura, Uta Dirksen, Thomas G. P. Grunewald
bioRxiv 498253; doi: https://doi.org/10.1101/498253
Subject Area
Subject Areas
- Biochemistry (11703)
- Bioengineering (8718)
- Bioinformatics (29127)
- Biophysics (14930)
- Cancer Biology (12048)
- Cell Biology (17353)
- Clinical Trials (138)
- Developmental Biology (9406)
- Ecology (14143)
- Epidemiology (2067)
- Evolutionary Biology (18266)
- Genetics (12219)
- Genomics (16765)
- Immunology (11841)
- Microbiology (28003)
- Molecular Biology (11551)
- Neuroscience (60804)
- Paleontology (450)
- Pathology (1864)
- Pharmacology and Toxicology (3229)
- Physiology (4939)
- Plant Biology (10383)
- Synthetic Biology (2877)
- Systems Biology (7333)
- Zoology (1642)